Explore the intricate role of reactive oxygen species (ROS) in cancer development and how shikonin and its derivatives can strategically target these molecules to induce cancer cell death, modulate signaling pathways, and enhance chemotherapy responsiveness, offering novel insights for anti-cancer therapy research and design.				
				
				
			Bitte wählen Sie Ihr Anliegen aus.
Rechnungen
Retourenschein anfordern
Bestellstatus
Storno







